Beta-blocker therapy for long QT syndrome and catecholaminergic polymorphic ventricular tachycardia: Are all beta-blockers equivalent?

Michael John Ackerman, Silvia G. Priori, Anne M. Dubin, Peter Kowey, Nicholas J. Linker, David Slotwiner, John Triedman, George F. Van Hare, Michael R. Gold

Research output: Contribution to journalArticle

23 Scopus citations
Original languageEnglish (US)
Pages (from-to)e41-e44
JournalHeart Rhythm
Volume14
Issue number1
DOIs
StatePublished - Jan 1 2017

Keywords

  • Beta-blockers
  • Catecholaminergic polymorphic ventricular tachycardia
  • Long QT syndrome
  • Nadolol
  • Sudden death

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)

Cite this

Ackerman, M. J., Priori, S. G., Dubin, A. M., Kowey, P., Linker, N. J., Slotwiner, D., Triedman, J., Van Hare, G. F., & Gold, M. R. (2017). Beta-blocker therapy for long QT syndrome and catecholaminergic polymorphic ventricular tachycardia: Are all beta-blockers equivalent? Heart Rhythm, 14(1), e41-e44. https://doi.org/10.1016/j.hrthm.2016.09.012